Apremilast for Lichen Planopilaris and Frontal Fibrosing Alopecia: A Case Series

    June 2017 in “ Skin
    Ali Hadi, Mark Lebwohl
    Image
    Studysummary This study is the first to report that apremilast may be effective in treating refractory lichen planopilaris and frontal fibrosing alopecia, though some patients experienced adverse effects leading to discontinuation. Our plain-language summary of this paper — not a Tressless recommendation.
    This retrospective case series analyzed the outcomes of four female patients with refractory lichen planopilaris or frontal fibrosing alopecia treated with apremilast. All patients had previously failed multiple treatments, including intralesional steroids, anti-malarials, and oral anti-inflammatory agents. Despite two patients discontinuing apremilast due to gastrointestinal discomfort, clinical improvement was observed in all cases. This study suggested that apremilast could be a potential treatment option for these conditions when other treatments have failed.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results